Daniel Karp in

Daniel Karp

Login to view DISC.
Executive Vice President, Corporate Development & Chief Strategy Officer at Organon
📍 United States

Daniel is a founding executive at Organon, where he serves as EVP of Corporate Development and Chief Strategy Officer. An alumnus of The Wharton School and Duke University, he has executed over $83 billion in transactions, focusing on bringing innovative drugs, therapies, and vaccines to patients.

He appears to be family-oriented, having shared his experience of bringing his daughter and son to a company work day. He finds inspiration in seeing his professional mission to create a healthier future through the eyes of his children, connecting his work to the next generation.

Unique fact: Daniel built and leads Organons global business development, including M&A, licensing, and integration, since the companys inception.

Read the full overview →
Experience
6 Years
Current Role
Executive Vice President, Corporate Development & Chief Strategy Officer
Job Level
Leadership
Location
United States
Personality Overview

How Daniel shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Daniel cares about

Women's Health Innovation
As a leader at Organon, a company dedicated to women's health, he is focused on deals that bring new drugs, devices, and technologies to this space.
Strategic Dealmaking
He leads all M&A, licensing, and collaborations, recently managing a key divestiture to reduce debt and an acquisition to expand Organon's biosimilars portfolio.
+5 more topics Login to view topics
Career

Work history

1-2021
Executive Vice President, Corporate Development & Chief Strategy Officer
Organon
5-2022
Director, Board of Directors
Cartesian Growth Corp II
2-2021 - 1-2023
Director, Board Of Directors
Cartesian Growth Corporation
1-2021 - 6-2021
SVP, Head of Business Development, Organon & Co
Merck
6-2018 - 3-2020
Executive Vice President, Corporate Development
Biogen
In the press

Media appearances

Organon Appoints Daniel Karp as Executive Vice President, Corporate Development. Featured in Organon Newsroom
See now
3 key insights to fostering successful collaboration in women's health. Featured in Bio.News
+3 more appearances Login to view media
Education
MBA
The Wharton School
BS
Duke University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Organon Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Daniel. Free, 10 seconds.